BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38071101)

  • 1. The Impact of Imaging-Diagnosed Sarcopenia on Long-term Prognosis After Curative Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Kong Q; Gao Q; Li W; Chen Z
    Acad Radiol; 2024 Apr; 31(4):1272-1283. PubMed ID: 38071101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
    Polvieng T; Hongjinda S; Thienhiran A; Burasakarn P; Fuengfoo P
    Am Surg; 2024 Jun; 90(6):1447-1455. PubMed ID: 38516765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing recent recurrence after hepatectomy for hepatitis B-related hepatocellular carcinoma by a predictive model based on sarcopenia.
    Peng H; Lei SY; Fan W; Dai Y; Zhang Y; Chen G; Xiong TT; Liu TZ; Huang Y; Wang XF; Xu JH; Luo XH
    World J Gastroenterol; 2024 Mar; 30(12):1727-1738. PubMed ID: 38617742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis.
    Wu DH; Liao CY; Wang DF; Huang L; Li G; Chen JZ; Wang L; Lin TS; Lai JL; Zhou SQ; Qiu FN; Zhang ZB; Chen YL; Wang YD; Zheng XC; Tian YF; Chen S
    Eur J Surg Oncol; 2023 Apr; 49(4):802-810. PubMed ID: 36586787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Zhang H; Zhang L; Wang Y; Zou J; Zhang T
    Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
    Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma.
    Voron T; Tselikas L; Pietrasz D; Pigneur F; Laurent A; Compagnon P; Salloum C; Luciani A; Azoulay D
    Ann Surg; 2015 Jun; 261(6):1173-83. PubMed ID: 24950264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Wang D; Su C; Li H; Guo X
    Oncotarget; 2015 Jul; 6(21):18715-33. PubMed ID: 26243835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
    Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
    Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
    HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis.
    Xu L; Jing Y; Zhao C; Zhang Q; Zhao X; Yang J; Wu L; Yang Y
    J Gastrointest Oncol; 2020 Oct; 11(5):1040-1053. PubMed ID: 33209496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
    Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
    Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.
    Harimoto N; Shirabe K; Yamashita YI; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y; Nishie A; Yamanaka T
    Br J Surg; 2013 Oct; 100(11):1523-30. PubMed ID: 24037576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma.
    Shimizu T; Ishizuka M; Suzuki T; Tanaka G; Park KH; Matsumoto T; Shiraki T; Sakuraoka Y; Kato M; Aoki T; Kubota K
    J Surg Oncol; 2017 Dec; 116(8):1166-1175. PubMed ID: 28853157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution.
    Vaghiri S; Prassas D; Mustafov O; Kalmuk S; Knoefel WT; Lehwald-Tywuschik N; Alexander A; Dizdar L
    BMC Surg; 2024 Apr; 24(1):101. PubMed ID: 38589847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Hepatic Pedicle Clamping on Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma: Stratified Analysis Based on Intraoperative Blood Transfusion Status.
    Tang SC; Xu JH; Yang YF; Shi JN; Lin KY; Kong J; Wang XM; Fan ZQ; Gu WM; Zhou YH; Liu HZ; Liang YJ; Shen F; Lau WY; Zeng YY; Yang T
    Ann Surg Oncol; 2024 Mar; 31(3):1812-1822. PubMed ID: 38038790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
    Chen W; Ma T; Zhang J; Zhang X; Chen W; Shen Y; Bai X; Liang T
    HPB (Oxford); 2020 Jun; 22(6):795-808. PubMed ID: 31980307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.